BACKGROUND: The VACTERL with hydrocephalus (VACTERL-H) phenotype is recognised to be a severe manifestation of autosomal recessive Fanconi anaemia. Several families have been described in which the VACTERL-H phenotype segregates as an X linked syndrome. The mutations which cause X linked VACTERL-H syndrome are not known. OBJECTIVE: To determine if mutations in FANCB, which are known to cause Fanconi anaemia complementation group B, are a cause of X linked VACTERL-H syndrome. METHODS: A three generation pedigree with X linked VACTERL-H syndrome was investigated. X inactivation was tested in carrier females, and fibroblasts from an affected male fetus were analysed for increased sensitivity to diepoxybutane. FANCB coding exons and flanking splice sites were screened for mutations by direct sequencing of polymerase chain reaction (PCR) fragments amplified from genomic DNA. cDNA from affected fetal fibroblasts was analysed by PCR and direct sequencing using specific exonic primers. RESULTS: A FANCB mutation which results in a premature stop codon by causing skipping of exon 7 was identified. Chromosomes from the affected fetus showed increased sensitivity to diepoxybutane, and carrier women were found to have 100% skewed X inactivation in blood. CONCLUSIONS: Mutations in FANCB are a cause of X linked VACTERL-H syndrome. The data presented are of relevance to the genetic counselling of families with isolated male cases of VACTERL-H and Fanconi anaemia.
BACKGROUND: The VACTERL with hydrocephalus (VACTERL-H) phenotype is recognised to be a severe manifestation of autosomal recessive Fanconi anaemia. Several families have been described in which the VACTERL-H phenotype segregates as an X linked syndrome. The mutations which cause X linked VACTERL-H syndrome are not known. OBJECTIVE: To determine if mutations in FANCB, which are known to cause Fanconi anaemia complementation group B, are a cause of X linked VACTERL-H syndrome. METHODS: A three generation pedigree with X linked VACTERL-H syndrome was investigated. X inactivation was tested in carrier females, and fibroblasts from an affected male fetus were analysed for increased sensitivity to diepoxybutane. FANCB coding exons and flanking splice sites were screened for mutations by direct sequencing of polymerase chain reaction (PCR) fragments amplified from genomic DNA. cDNA from affected fetal fibroblasts was analysed by PCR and direct sequencing using specific exonic primers. RESULTS: A FANCB mutation which results in a premature stop codon by causing skipping of exon 7 was identified. Chromosomes from the affected fetus showed increased sensitivity to diepoxybutane, and carrier women were found to have 100% skewed X inactivation in blood. CONCLUSIONS: Mutations in FANCB are a cause of X linked VACTERL-H syndrome. The data presented are of relevance to the genetic counselling of families with isolated male cases of VACTERL-H and Fanconi anaemia.
Authors: Marieke Levitus; Quinten Waisfisz; Barbara C Godthelp; Yne de Vries; Shobbir Hussain; Wouter W Wiegant; Elhaam Elghalbzouri-Maghrani; Jûrgen Steltenpool; Martin A Rooimans; Gerard Pals; Fré Arwert; Christopher G Mathew; Małgorzata Z Zdzienicka; Kevin Hiom; Johan P De Winter; Hans Joenje Journal: Nat Genet Date: 2005-08-21 Impact factor: 38.330
Authors: Amom Ruhikanta Meetei; Annette L Medhurst; Chen Ling; Yutong Xue; Thiyam Ramsing Singh; Patrick Bier; Jurgen Steltenpool; Stacie Stone; Inderjeet Dokal; Christopher G Mathew; Maureen Hoatlin; Hans Joenje; Johan P de Winter; Weidong Wang Journal: Nat Genet Date: 2005-08-21 Impact factor: 38.330
Authors: Amom Ruhikanta Meetei; Marieke Levitus; Yutong Xue; Annette L Medhurst; Michel Zwaan; Chen Ling; Martin A Rooimans; Patrick Bier; Maureen Hoatlin; Gerard Pals; Johan P de Winter; Weidong Wang; Hans Joenje Journal: Nat Genet Date: 2004-10-24 Impact factor: 38.330
Authors: L Faivre; P Guardiola; C Lewis; I Dokal; W Ebell; A Zatterale; C Altay; J Poole; D Stones; M L Kwee; M van Weel-Sipman; C Havenga; N Morgan; J de Winter; M Digweed; A Savoia; J Pronk; T de Ravel; S Jansen; H Joenje; E Gluckman; C G Mathew Journal: Blood Date: 2000-12-15 Impact factor: 22.113
Authors: Benjamin D Solomon; Kelly A Bear; Virginia Kimonis; Annelies de Klein; Daryl A Scott; Charles Shaw-Smith; Dick Tibboel; Heiko Reutter; Philip F Giampietro Journal: Am J Med Genet A Date: 2012-11-19 Impact factor: 2.802
Authors: Xiaoli Li; Liang Li; Jie Li; Jared Sipple; Jonathan Schick; Parinda A Mehta; Stella M Davies; Biplab Dasgupta; Ronald R Waclaw; Qishen Pang Journal: Antioxid Redox Signal Date: 2014-03-12 Impact factor: 8.401
Authors: Olga M Moreno; Ana I Sánchez; Angélica Herreño; Gustavo Giraldo; Fernando Suárez; Juan Carlos Prieto; Ana Shaia Clavijo; Mercedes Olaya; Yaris Vargas; Javier Benítez; Jordi Surallés; Adriana Rojas Journal: Mol Syndromol Date: 2020-11-11
Authors: Moonjung Jung; Ramanagouda Ramanagoudr-Bhojappa; Sylvie van Twest; Rasim Ozgur Rosti; Vincent Murphy; Winnie Tan; Frank X Donovan; Francis P Lach; Danielle C Kimble; Caroline S Jiang; Roger Vaughan; Parinda A Mehta; Filomena Pierri; Carlo Dufour; Arleen D Auerbach; Andrew J Deans; Agata Smogorzewska; Settara C Chandrasekharappa Journal: Blood Date: 2020-04-30 Impact factor: 25.476